Hologic airs validating data for Aptima STI test
November 12, 2019 -- A study demonstrating the effectiveness of Hologic's Aptima assay for the increasingly common sexually transmitted infection (STI) Mycoplasma genitalium has been published in the Journal of Clinical Microbiology.
Myriad's prenatal test achieves high accuracy with low failure rate
November 12, 2019 -- Myriad Genetics' Prequel Prenatal Screen cell-free DNA test achieved high accuracy with no fetal fraction threshold, while maintaining a low test-failure rate of 1 in 1,000, in a study published in Ultrasound in Obstetrics & Gynecology.
AMP highlights: Products aim to beat the clock in cancer detection
November 11, 2019 -- Cancer was a key focus at the recent Association for Molecular Pathology (AMP) annual meeting in Baltimore -- particularly faster detection and treatment selection, according to Bruce Carlson, publisher of Kalorama Information.  Discuss
Invitae acquires Clear Genetics for $50M
November 11, 2019 -- Invitae is acquiring Clear Genetics, a developer of software that provides genetic services at scale, for about $50 million, consisting of approximately $25 million in cash and the remainder in shares of Invitae common stock.
Bio-Rad launches QX One PCR system at AMP 2019
November 11, 2019 -- Bio-Rad Laboratories announced the release of its QX One Droplet Digital polymerase chain reaction (ddPCR) system at the Association for Molecular Pathology (AMP) meeting, held November 7-9 in Baltimore.
What will it take for home cervical cancer testing to take off?
November 8, 2019 -- Self-sampling by women for cervical cancer screening promises to be highly effective clinically, though practical hurdles remain in terms of implementation on a large scale, according to new studies reported this week.  Discuss
Lexent Bio partners on NGS with Illumina
November 8, 2019 -- San Francisco-based Lexent Bio has signed a nonexclusive deal to adapt its lead investigational Confera Dx next-generation sequencing (NGS) cancer test for use with Illumina's NextSeq 550Dx sequencer.
DxTerity launches interferon test for lupus
November 8, 2019 -- California-based genomics company DxTerity is releasing data showing the association between type 1 interferon (IFN-1) and the development of systemic lupus erythematosus on November 11 at the American College of Rheumatology annual meeting. The data support the commercial launch of a test for the overexpression of IFN-1, the company said.
AMP roundup: Vendors showcase same-day NGS, faster prep, DNA/RNA combos
November 7, 2019 -- BALTIMORE - Bruce Carlson, publisher of Kalorama Information, is on the ground at the Baltimore Convention Center for this week's Association for Molecular Pathology (AMP) meeting, reporting on product introductions.  Discuss
Grifols promotes free COPD cheek swab test
November 7, 2019 -- Grifols announced it is offering a genetic cheek swab test that screens for alpha-1 antitrypsin deficiency in patients with chronic obstructive pulmonary disease (COPD) for free -- including testing and results.